Latest News Releases From The Newsroom
Eightco's Forever 8 Renews IMA with Mobi-hub, Tencent Music Entertainment and iQIYI Upgraded
May 17th, 2023
Eightco Holdings Inc. (Nasdaq: OCTO) made an announcement regarding its subsidiary, Forever 8. The company has successfully renewed and expanded its Inventory Management Agreement (IMA) with Mobi-hub Ltd., a prominent electronics distributor speciali. Read more
ServiceNow Announces Share Repurchase Program, Target Exceeds Q1 Earnings Estimates, Sunrise New Energy Reports Impressive Revenue Growth
May 17th, 2023
ServiceNow, Inc. (NYSE: NOW) made an important announcement regarding its financial strategy. The company's Board of Directors has approved the initiation of a share repurchase program, marking the first of its kind for ServiceNow. This new program a. Read more
SEC Charges 10 Microcap Companies with Securities Offering Registration Violations
May 16th, 2023
FOR IMMEDIATE RELEASE 2023-94 Washington D.C. / CRWE PRESS RELEASE / May 16, 2023 — The Securities and Exchange Commission today announced charges against 10 microcap companies for offering and selling securities in unregistered . Read more
Keysight Beats Expectations, Kyndryl Falls Short; Northrop Grumman Declares Dividend, EVgo Launches Public Offering
May 16th, 2023
Keysight Technologies, Inc. (NYSE: KEYS) has released its financial results for the second fiscal quarter ending April 30, 2022. The company reported earnings per share (EPS) of $2.12, surpassing the consensus estimate of $1.95. Following the posi. Read more
FTC Takes Legal Action to Halt Amgen's Acquisition of Horizon Therapeutics Amid Monopoly Concerns, Applied Digital Secures Major AI Customer, Etsy Faces Price Target Revision
May 16th, 2023
The Federal Trade Commission (FTC) has taken action to prevent the acquisition of Horizon Therapeutics plc (Nasdaq: HZNP) by the biopharmaceutical giant, Amgen Inc. (Nasdaq: AMGN). In its efforts to block the transaction, the FTC has filed a lawsuit . Read more
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
May 16th, 2023
The $27.8 billion acquisition of Horizon Therapeutics plc would enable Amgen Inc. to stifle competition for thyroid eye disease and chronic refractory gout treatments, the agency says LAS VEGAS, NV / CRWE PRESS RELEASE / May 16, 2023 - The F. Read more
Stratasys Reports Strong Q1 Earnings, MINISO Exceeds Expectations, Upgrades for Expedia and Royal Caribbean
May 16th, 2023
Stratasys Ltd. (Nasdaq: SSYS) has delivered positive adjusted earnings per share for the seventh consecutive quarter. In the first quarter of 2023, the company reported an EPS of $0.02, surpassing the consensus estimate of a loss of $0.06 per share. . Read more
Phio Pharmaceuticals' IND Cleared by FDA, YS Biopharma Advances in Rabies Vaccine Trial, Gilead Sciences Upgraded
May 16th, 2023
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) has announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for its lead product candidate, PH-762. This will allow Phio to proceed with. Read more
Home Depot's Q1 2023 Earnings Beat Expectations, Lowers Guidance; Baidu Surpasses Estimates, Allot Falls Short of Consensus, VivoPower Partners for EV Solutions
May 16th, 2023
The Home Depot, Inc. (NYSE: HD) has released its financial report for the first quarter of fiscal 2023, revealing that its earnings per share (EPS) stood at $3.82, slightly surpassing the consensus estimate of $3.80. However, the company fac. Read more
VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
May 15th, 2023
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04. In after-hours tradi. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login